Early test of new Under-the-Tongue tablet in asian volunteers
NCT ID NCT07464535
Summary
This early-stage study aimed to understand how the body processes two different doses of an experimental under-the-tongue tablet called TNX-102 SL. It involved 20 healthy Japanese and Chinese volunteers to see how the drug moves through their bodies and to check for any side effects. The main goal was to gather basic safety and dosing information, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS (HS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Los Angeles, Inc.
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.